Method for quantitative evaluation of a rearrangement or a targeted genetic recombination of an individual and uses thereof
CA 2548053 C · Owner: Commissariat A L'Energie Atomique · Inventors: Pasqual, Nicolas; Jouvin-Marche, Evelyne; Marche, Patrice
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for quantitative evaluation of a rearrangement or targeted genetic recombination of an individual and the immunity repertoire of an individual and the uses thereof particularly in the case of follow-up to a treatment or in the diagnosis and/or prognosis of certain pathologies. Said method comprises at least: (a) extraction of human genomic DNA from a biological sample (b) amplification of a segment of said genomic DNA the size thereof ranging from a few hundreds of base pairs and several quantities of ten kb by multiplex PCR in the presence of: one or several couples of primers and polymerase DNA or a polymerase DNA mixture enabling the amplification of segments of genomic DNA the …
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 3, 2004 and granted July 8, 2014. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended December 3, 2024.
- Certificates of supplementary protection extend only drug patents, and it isn't classified as one.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.